The UAE has become the second country to approve once-daily, oral pill - Lipfendra - to treat adults with elevated low-density lipoprotein (LDL-C) cholesterol, a leading risk factor for cardiovascular disease.
Making the announcement, the Emirates Drug Establishment (EDE) explained that Lipfendra can also treat "certain inherited conditions" as long as it is cleared by a healthcare professional.
It is said to expand treatment options for adults and improve their quality of life.
Patients are advised to maintain a balanced diet and regular physical activity alongside the treatment.
The move is part of efforts by the UAE to authorise innovative medicines and expand treatment options for adults.
UAE and Oman leaders discuss stronger ties, regional stability
UAE approves new oral treatment for vitiligo patients
UAE gives motorists chance to reduce black points on 'Accident-Free Day'
UAE join 7 nations in condemning Israeli rejection of Gaza peace plan
Fujairah seizes 21 illegal lobster traps in Dibba sea
